IRCCS
Institut de
Recherche Clinique
sur les cancers et le sang

The IRCCS association acts as a driving force of progress in health, by providing the hematology department of Lyon Sud Hospital with a clinical research support structure encompassing all the necessary players.

393

Participating patients in 2024

25

People dedicated to hematology research

91.4%

satisfaction of our partners

Photo credits: Olivier Ramonteu

EXPERTISE

A European reference center in clinical research

A large network of patients

In 2024, 393 patients participated in a hematology clinical trial thanks to our structure, including 87 in early phase trials. Clinical studies are carried out in both myeloid and lymphoid hematology fields.

A center at the forefront of innovation

The treatments or treatment regimens evaluated today in clinical trials are the therapeutic strategies of tomorrow. Our center is at the forefront of medical innovation by offering our patients trials of new therapies, such as CAR-T cells or combined approaches limiting conventional chemotherapy.

More than 20 years of experience

Founded in 2000, IRCCS operational structure has become a major partner in clinical research in hematology, recognized as a third-party structure by the Hospices Civils de Lyon (HCL).

Browse the list of our trials

IRCCS stands out for its role as an intermediary between the different stakeholders (researchers, clinicians, patients, funders) and for its ethical and innovative commitment.

Latest publications

Find the latest news from IRCCS

Events Published on 07/01/2025

Regional Post-ASH Day

We are pleased to inform you of the organization of the Regional Post ASH Day, which will be held on March 21, 2025 at the Lyon Sud University Hospital. This event is a unique opportunity to share scientific information and news on the latest advances in the field of hematology (allografts, AML and ALL, myelodysplastic syndromes, lymphomas, benign haematology, PNH, aplasia and myeloproliferative syndromes, multiple myeloma and CLL). We hope to see many of you for this event that brings together the hematological community of the region.

Fundamental research Published on 20/12/2024

A grant of €640,500 from the Ligue Contre le Cancer for Prof. BACHY’s Team: Towards a New Approach to CAR T Cells

In response to the 2024 call for proposals of the Ligue Contre le Cancer "Innovative cell therapies in oncology: new vectors, new targets", Prof. Emmanuel BACHY's team has obtained a grant of € 640,500 for the project "Functional improvement of CAR-T cells by Boolean and epigenetic approaches". This 3-year project is being carried out in collaboration with Prof. Olivier Hermine, Head of the Hematology Department at Necker Hospital and Director of Inserm Unit U1163 at the Imagine Institute in Paris, Prof. Michel Sadelain, Head of the Center for Cell Engineering at Memorial Sloan Kettering Cancer (MSKCC) in New York and Dr. Laurent Genestier, co-director of the Lymphoma Immunobiology team in Lyon (LIB) Inserm U1111-CNRS UMR 5308.

Events Published on 07/12/2024

Dr Maël Heiblig in the spotlight: oral participation at ASH 2024

Session: 615. Acute Myeloid Leukemias: Clinical and Epidemiology: Genetic Markers and Outcomes in AML

Join clinical research

Clinical research is one of the missions of the hematology department of Lyon Sud Hospital. It is ensured at the operational level by the IRCCS structure marked by:

Innovation

Our partners (academic or industrial societies) trust us to provide our patients with innovative therapies such as CAR-T cells or “first in Human” trials.

Multidisciplinary teamwork

The structure is entirely dedicated to clinical research. It manages all aspects of studies, namely all administrative procedures from the opening to the closing of the trials, but also treatment and monitoring of patients. All stakeholders share the desire to further research together with medical teams.

Professional development and expertise

- Work in a constantly evolving field, allowing you to broaden your technical and scientific skills - Benefit from continuing training through collaboration with multidisciplinary experts and participation in scientific conferences or congresses

Check out our job offers

The main mission of IRCCS is the organization and management of therapeutic or non-interventional studies of hematological cancers and blood diseases, including participation in national and international multicenter studies. A dedicated team of 25 clinical research professionals works within this structure integrated into the clinical hematology department of the Hospices Civils de Lyon at Lyon Sud Hospital.

Pr Hervé Ghesquières

Research needs you

Make a donation

If you wish to support any action of general interest related to blood diseases:

I give

IRCCS Institut de Recherche Clinique sur les cancers et le sang